A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset. — Stella
A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset.
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(9 sites)
China
Harrison International Peace Hospital, Hengshui, Hebei
Daqing Oilfield General Hospital, Daqing, Heilongjiang
The First Affiliated Hospital of Nanyang Medicinal College, Nanyang, Henan
MeiHekou Central Hospital, Meihekou, Jilin
The Affiliated Hospital of Shenyang Medical College, Shenyang, Liaoning
Xianyang Hospital of Yan'an University, Xianyang, Shaanxi
Linyi People's Hospital, Linyi, Shandong
Linfen Central Hospital, Linfen, Shanxi
Beijing Tiantan Hospital , Capital Medical University, Beijing